Tradestie Institutional Equity Comparison Engine
CDT vs ABVEW โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABVEW Overall Edge
ABVEW Captures Institutional Edge (2โ1 Pillars ยท 2โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Above Food Ingredients Inc. Warrants (ABVEW) driven by superior Momentum & Technical, Options & Structure while CDT counters with relative strength in Growth & Margin. Fundamentally, CDT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABVEW at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CDT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ABVEW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CDT N/M vs ABVEW N/M Fwd P/E
Growth & Margin Winner
CDT
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
ABVEW
1Y -86.8% vs -64.7% ยท 52W Pos 2% vs 0%
Options & Structure Winner
ABVEW
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
CDT
NASDAQ
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap
$507,528
1M Return
+76.79%
1Y Return
-86.78%
Forward P/E
N/M
Unified AI Score
31.6 / 100
SELL
Tech 15.0
Fund 37.0
Flow 50.0
Mom 54.0
ABVEW
NASDAQ
Above Food Ingredients Inc. Warrants
Institutional Equity
$0.02
-86.37% 1D
Market Cap
N/A
1M Return
-87.14%
1Y Return
-64.71%
Forward P/E
N/M
Unified AI Score
37.2 / 100
SELL
Tech 25.0
Fund 42.0
Flow 50.0
Mom 53.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CDT -86.78%
ABVEW -64.71%
Spread: +48.39 pp (CDT Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CDT TTM Op. Margin: 0.0%
ABVEW TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CDT vs ABVEW. Trailing 12-month operating profitability (CDT 0.0% vs ABVEW N/A) and valuation multiples (CDT N/M vs ABVEW N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CDT | ABVEW | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $507,528 | N/A | Larger Scale | CDT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | CDT |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | CDT |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | CDT |
| Return on Equity (ROE) Capital Efficiency | -69.7% | N/A | Higher ROE | CDT |
| 52-Week Range Position Momentum | 2% ($0โ$11) | 0% ($0โ$2) | Stronger Trend | CDT |
| Beta / 30D Volatility Risk Regime | -17.75ฮฒ ยท 10175% Vol | 4.07ฮฒ ยท 408% Vol | Lower Realized Risk | ABVEW |
| Unified Institutional Score Composite Signal | 31.6 / 100 (SELL) | 37.2 / 100 (SELL) | Higher Composite | ABVEW |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CDT vs ABVEW Buy Guide
CDT
BREAKDOWN
163d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ABVEW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CDT nor ABVEW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.